Analysis of efficacy, safety and prognostic factors of DAC-HAA treatment in Chinese pediatric patients with refractory or relapsed acute myeloid leukemia

Hematopoietic stem cell transplantation (HSCT) is generally considered as the only effective treatment for children with relapsed/refractory (R/R) acute myeloid leukemia (AML). Achieving remission prior to HSCT affects the efficacy of the procedure and patient survival; therefore, induction therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liang, Li, Chun, Xu, Fang, Cao, Fang, Zhang, Bo, Wang, Jing, Wang, Shen, Chen, Li, Li, Na, Liao, Chenglin, Liu, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591692/
https://www.ncbi.nlm.nih.gov/pubmed/34790353
http://dx.doi.org/10.3892/mco.2021.2431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591692/
https://www.ncbi.nlm.nih.gov/pubmed/34790353
http://dx.doi.org/10.3892/mco.2021.2431

Ejemplares similares